Meyka AI API is live for developers.Start building.
Advertisement
Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc. (NEUP) Stock Overview

Explore Neuphoria Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

NEUP●NASDAQ
HealthcareMedical - Pharmaceuticals
$4.45
$0.10(2.34%)
U.S. Market is Open · 10:08
Advertisement

Neuphoria Therapeutics Inc. (NEUP)

Meyka AI Score

Z

Key Financials

Market Cap24.7M
P/E Ratio-0.40
EPS (TTM)$-11.06
ROE-1.10%
Fundamental Analysis

AI Price Forecasts

1 Month$5.53
3 Months$10.66
1 Year Target$3.70

NEUP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Neuphoria Therapeutics Inc. (NEUP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.40 and a market capitalization of 24.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.06%
5-Day Change
5.54%
1-Month Change
-16.30%
3-Month Change
988.10%
6-Month Change
1128.49%
Year-to-Date (YTD) Change
1077.84%
1-Year Change
572.06%
3-Year Change
1766.83%
5-Year Change
2485.43%
All-Time (Max) Change
2485.43%

Contact Information

http://www.neuphoriatx.com
NaN
100 Summit Dr, Burlington, NaN, NaN

Company Facts

80 Employees
IPO DateDec 16, 2021
CountryUS
Actively Trading

Frequently Asked Questions